The global antidepressant drugs market is anticipated to grow at a significant CAGR of 3.1% during the forecast period. Antidepressants are the most widely prescribed medications to treat anxiety disorders, moderate persistent depression, and MDD symptoms. These medications are used to repair chemical imbalances in the brain that may be causing behavioral and mood abnormalities. Antidepressants are divided into four categories: SSRIs, SNRIs, tricyclic antidepressants, and monoamine oxidase inhibitors. These antidepressants, such as SSRIs, act by inhibiting the reuptake of specific neurotransmitters (chemical messengers) and thereby increasing their levels throughout the brain nerves.
To Request a Sample of our Report on Global Antidepressant Drugs Market: https://www.omrglobal.com/request-sample/antidepressant-drugs-market-size
Increased depression and stress levels, as well as a growing geriatric population, are driving market expansion. Older people are more susceptible to diseases such as subsyndromal depression and other stress-related disorders. According to World Health Organization (WHO), an estimated 3.8% of the population, including 5.0% among adults and 5.7% among elders older than 60 years is suffering from depression which accounts for 280 million people globally in 2021. Other causes, such as chronic medical illnesses, crimes such as sexual assault and femicide, and other behavioral disorders, may contribute to depression, resulting in a requirement for antidepressant medications. However, lack of availability of proper guidance, lack of awareness among people regarding mental depression in developing economies, and medicine patent expiration are some of the market’s restraints. Nonetheless, the introduction of new and improved medications with fewer side effects is expected to expand the market in the future.
A full Report of Global Antidepressant Drugs Market is Available @ https://www.omrglobal.com/industry-reports/antidepressant-drugs-market-size
Global Antidepressant Drugs Market Segmentation
- By Depressive Disorder
- Major Depressive Disorder (MDD)
- Obsessive-Compulsive Disorder (OCD)
- Generalized Anxiety Disorder (GAD)
- Panic Disorder (PD)
- Other Depressive Disorder
By Drug Class
- Selective Serotonin Reuptake Inhibitors (SSRI)
- Serotonin and Norepinephrine Reuptake Inhibitors (SNRI)
- Tricyclic Antidepressants (TCA)
- Monoamine Oxidase Inhibitors (MAOI)
- Other Medications (Atypical Antidepressants)
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Company Profiles
- Camber Pharmaceutical Inc.
- Eli Lilly & Co.
- GlaxoSmithKline PLC
- Lundbeck A/S
- Intellipharmaceutics International Inc.
- Johnson & Johnson Services Inc.
- Merck & Co., Inc.
- Mylan Pharmaceutical Ltd.
- Novartis International AG
- Pfizer Inc.
- Sanofi S.A.
- Sun Pharmaceuticals Ltd.
- Takeda Pharmaceutical Co.
- Teva Pharmaceutical Industries Ltd.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/antidepressant-drugs-market-size
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
